CSafe Global has recently received approval for its new CSafe RAP active container from the European Aviation Safety Agency. With this new approval, along with the FAA approval granted in November 2017, CSafe Global now provides greater opportunities for pharmaceutical and life science companies to ship their temperature-sensitive products globally.

Brian Kohr, President and CEO of CSafe Global, remarked: “The EASA approval of our new active RAP system is very important in our mission to provide cold chain solutions that ensure successful delivery of life enhancing products around the world. With this approval, we mark another important milestone in the launch of the CSafe RAP, providing life science shippers with a new temperature-controlled container solution, for larger cargo payloads, that is based on our proven system designs and technologies that have been used in successful shipments with the CSafe RKN active container over the past ten years.”